The study cited in rumors about the negative effects of sunscreen did not actually draw the conclusion shared by some people ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced ...

Good results reported with emergency-use and compassionate-use cases ...

The question is not how clinicians can be made more resilient. It is why an institution performing at the highest level of ...

Lundbeck to present new data of eptinezumab and bocunebart EAN Congress 2026 on June 27-30 in Geneva: Valby, Denmark Friday, June 26, 2026, 13:00 Hrs [IST] H. Lundbeck A/S (Lundbe ...

Apnimed, Inc., a late-stage clinical pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep-related ...

Priority review positions satralizumab as a potentially practice-shifting alternative to IV IGF-1R inhibitors, primarily differentiated by subcutaneous self-administration and at-home dosing. Two ...

Much of what is known about Ebola virus disease comes from outbreaks of Orthoebolavirus zairense and Orthoebolavirus sudanense. Although these provide important lessons for the current response, ...

Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the definition of HF and its antecedent stages have limited research, global ...

A new study suggests that pre-eclampsia may raise the risk of chronic kidney disease, high blood pressure, and heart disease ...

Cho shared that she endured kidney damage after going on the weight loss cocktail Fen-phen ...

Dr. Angelo Hooker from Zaans Medical Center (ZMC) discusses the causes, impacts, and ways forward for the prevention of intrauterine adhesions (IUAs) ...